Twenty-four hour steroid avoidance immunosuppressive regimen in liver transplant recipients

Experimental and Clinical Transplantation

Volumn 10, Issue 3, 2012, Pages 258-262

  Ju, Wei Qiang ^a   Guo, Zhi Yong ^a   Ling, Xiaoting ^a   He, Xiao Shun ^a   Wu, Lin Wei ^a   Tai, Qiang ^a   Hu, An Bin ^a   Han, Ming ^a   Zhu, Xiao Feng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Basiliximab; Immunosuppression; Liver transplant; Steroids; Tacrolimus

Indexed keywords

BASILIXIMAB; GLUCOSE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CAUSE OF DEATH; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN TREATMENT; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MYCOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CHINA; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; RISK FACTORS; STEROIDS; TACROLIMUS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 84862619500     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2010.0127     Document Type: Article

References (8)

1. He Xiao-shun, Hu An-bin. Development of steroids protocol in liver transplantation, Chinese J Surg. 2008;46:1123-1125.
2. Toyoki Y, Hakamada K, Narumi S, et al. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience. Transplant Proc. 2004;36(8):2279-2281.
3. Innocenti F, Hepp J, Humeres R, et al. Rapid steroid taper and neoral monotherapy in liver transplantation in Chile: a step in the right direction? Transplant Proc. 2004;36(6):1675-1676.
4. Hu An-bin, He Xiao-shun, Wu Zhi-peng, et al. Clinical Evaluation of steroids withdrawal at 7 days postoperation in liver transplantation. Chinese J Surg. 2008;46:1126-1128.
5. Liu CL, Fan ST, Lo CM, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl. 2004;10(6):728-733.
6. Marubashi S, Dono K, Amano K, et al. Steroid-free living-donor liver transplantation in adults. Transplantation. 2005;80(5):704-706.
7. Ringe B, Braun F, Schütz E, et al. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Transplantation. 2001;71(4):508-515.
8. Lladó L, Xiol X, Figueras J, et al. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study. J Hepatol. 2006;44(4):710-716. Erratum in: J Hepatol. 2006;45(1):166.